Abstract
With the aid of IGF2 and VEGF in situ hybridization; tyrosine hydroxylase, chromogranin A, and Ki67 immunohistochemistry; and TUNEL staining applied to a large series of clinical neuroblastomas and to an animal model, we show here that stroma-poor neuroblastomas show evidence of chromaffin differentiation similar to that of type 1 small intensely fluorescent (SIF) cells and that this occurs in a vascular-dependent fashion, indicating a role for local tumor hypoxia in the differentiation process.
MeSH terms
-
Animals
-
Apoptosis
-
Biomarkers
-
Cell Differentiation
-
Cell Hypoxia
-
Chromaffin Cells / chemistry*
-
Chromogranin A
-
Chromogranins / analysis
-
Endothelial Growth Factors / analysis
-
Ganglioneuroblastoma / chemistry
-
Ganglioneuroblastoma / metabolism
-
Ganglioneuroblastoma / pathology*
-
Ganglioneuroma / chemistry
-
Ganglioneuroma / metabolism
-
Ganglioneuroma / pathology*
-
Humans
-
In Situ Nick-End Labeling
-
Insulin-Like Growth Factor II / analysis
-
Ki-67 Antigen / analysis
-
Lymphokines / analysis
-
Neoplasm Proteins / analysis
-
Neoplasm Transplantation
-
Neuroblastoma / blood supply
-
Neuroblastoma / chemistry
-
Neuroblastoma / metabolism
-
Neuroblastoma / pathology*
-
Oxygen / metabolism*
-
Rats
-
Rats, Nude
-
Sympathetic Nervous System / chemistry
-
Sympathetic Nervous System / cytology
-
Sympathetic Nervous System / embryology
-
Transplantation, Heterologous
-
Tyrosine 3-Monooxygenase / analysis
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
Substances
-
Biomarkers
-
Chromogranin A
-
Chromogranins
-
Endothelial Growth Factors
-
Ki-67 Antigen
-
Lymphokines
-
Neoplasm Proteins
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factors
-
Insulin-Like Growth Factor II
-
Tyrosine 3-Monooxygenase
-
Oxygen